From Evan Harris <[email protected]>
Subject Dr. Henry Miller Breaks Down New Coronavirus Studies
Date June 15, 2020 5:59 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])
Dr. Henry Miller Breaks Down New Coronavirus Studies
The John Batchelor Show | Henry Miller, M.S., M.D.
June 11, 2020

Dr. Henry Miller joins the John Batchelor Show to discuss the release of two studies measuring the impact of infections and deaths due to the coronavirus. A Berkeley study said that the shutdowns could have prevented 120 million novel coronavirus infections in the United States, and about 600 million in China. The other study, from the Imperial College London, 3.1 million lives across 11 European countries, shutdowns dropped infection rates by an average of 82 percent. Miller and John Batchelor also analyze the credibility of data from Russia and China.
Listen here. . . ([link removed])

Coronavirus Stimulus Would Barely Cover Medicare for All
Townhall.com | Sally C. Pipes
June 10, 2020

Medicare for All would eliminate private insurance and enroll every American in a government-run plan. These plans would cover everything from checkups and surgeries to dental and long-term care, free of charge. Patients wouldn’t face premiums, deductibles, or copays.
Read more. . . ([link removed])

Pandemics, Pollution and Poppycock
Human Events | Henry I. Miller, M.S., M.D. and Andrew I. Fillat
June 15, 2020

With the world in the grip of the COVID-19 pandemic, most of the short-term focus is now on how to avoid surges of infections and get the economy functioning so people can go back to work. Hindsight is, of course, 20-20.

Many lessons about pandemics will be learned in retrospect—the most notable being the need for epidemiological surveillance, preparedness with stockpiles of medical supplies, and how not to handle the most vulnerable population during an infectious disease crisis (in this case, people in long-term care facilities).

Read more. . . ([link removed])

The WHO Follies, Redux
Issues & Insights | Henry I. Miller, M.S., M.D. and Jeff Stier
June 8, 2020

The day after Van Kerkhove’s misstatement, WHO convened a news conference to walk back her comments, stressing that much remains unknown. But the comment from Monday had already gone viral (pardon the expression) and been seized upon by those who believe that people do not need to wear masks or observe social distancing precautions. Calling the controversy “a misunderstanding,” Van Kerkhove clumsily tried to perform damage control.

Read more. . . ([link removed])
[link removed]
PRI Drug Pricing Video #6 - Digging Up Ways to Lower Costs for High Value but Expensive Drugs ([link removed])
Sage the Detective Dog digs up clues on biologics and gene therapies – drugs that offer tremendous value for patients but are some of the most expensive drugs. Along the way, the Professor and Pete Paystoomuch learn that there are many distinct challenges to develop markets for competition and lower drug costs for each unique class of drug.

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis